BRIGHTON AESTETICS LTD
Company number 13667050 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
BRIGHTON AESTETICS LTD - Analysis Report
Company Number: 13667050
Analysis Date: 2025-07-20 11:42 UTC
Risk Rating: MEDIUM
Brighton Aestetics Ltd demonstrates modest net current assets and positive shareholders' funds, indicating an ability to meet short-term obligations. However, the company is relatively new (incorporated in 2021), with limited financial history and a significant drop in net current assets and equity from 2022 to 2023. The overdue confirmation statement filing also raises a minor regulatory compliance concern.Key Concerns:
- Declining Financial Position: Shareholders’ funds decreased from £13,909 in 2022 to £6,626 in 2023, and net current assets dropped from £10,094 to £3,764, suggesting profitability or cash flow pressures.
- Overdue Confirmation Statement: The latest confirmation statement is overdue since 31 August 2024, indicating a lapse in statutory compliance which could lead to penalties or signal governance weaknesses.
- Director Turnover and Control Concentration: One director resigned in August 2023 and was replaced by a new director with the same individual controlling 75-100% of shares, indicating concentrated control and potential governance risk.
- Positive Indicators:
- Positive Net Current Assets and Shareholders’ Funds: The company maintains a positive working capital position and equity, implying it can meet short-term liabilities.
- No Overdue Accounts Filing: The latest accounts were filed on time with no audit requirement, consistent with its small company status, reducing regulatory risk.
- Industry Focus: Operating in the hairdressing and beauty treatment sector (SIC 96020), which can have stable demand, and the company appears to have a clear operational focus.
- Due Diligence Notes:
- Investigate the cause of the significant decrease in net current assets and shareholders’ funds between 2022 and 2023, including review of profitability, cash flow, and any extraordinary expenses or losses.
- Confirm the status and intentions regarding the overdue confirmation statement filing and evaluate overall compliance culture.
- Review director changes and concentration of control implications, including any potential related-party transactions or governance issues.
- Assess the company’s business model sustainability, client base, and competitive positioning within the beauty treatment sector.
- Consider requesting management accounts or cash flow forecasts given the limited historical data due to the company’s recent incorporation.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.